A collection of 27 states and the District of Columbia wrote to the Department of Health and Human Services (HHS) imploring the agency to rein in drugmakers they say are restricting access to 340B discounted drugs. The letter, released Monday, is the latest salvo in an escalating feud between 340B covered entities and drug companies who have restricted sales to contract pharmacies, which are third-party entities that dispense 340B-discounted products. The letter comes after a collection of hospital groups sued HHS Friday to spur the agency into action.
Read the full article: 27 States and D.C. Call for HHS to Rein in Drugmakers over 340B Moves after Hospital Group Lawsuit //
Source: https://www.fiercehealthcare.com/hospitals/27-states-and-d-c-call-for-hhs-to-rein-drug-makers-over-340b-moves-after-hospital-group